CHMMFChimeric Therapeutics Limited

$0.10
$2.90
(96.67%)
Today
Updated: 12:03 PM EDT
Mkt Cap$53,900.00
Vol300.00

About

Chimeric Therapeutics Ltd. is a clinical stage cell therapy company, which engages in the development and commercialization of cell therapies in oncology. Its products include NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company was founded by Paul A. Hopper in 2020 and is headquartered in Carlton South, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Chimeric Therapeutics Limited?
What is the 52-week high for Chimeric Therapeutics Limited?
What is the 52-week low for Chimeric Therapeutics Limited?
What is Chimeric Therapeutics Limited stock price today?
What was Chimeric Therapeutics Limited stock price yesterday?
What is the Price-to-Book ratio of Chimeric Therapeutics Limited?
What is the 50-day moving average of Chimeric Therapeutics Limited?

Latest CHMMF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.